IP Library Granted Patent US 10,639,336
Granted Patent B1
US 10,639,336 · App. 16/435,944 · Granted May 5, 2020

Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke

Inventors: Yi-Hsing Chen (Tainan, TW); Wan-Hua Tsai (Kaohsiung, TW); Shiang-Suo Huang (Taipei, TW); Yi-Hsin Wang (Tainan, TW)
Assignee: GENMONT BIOTECH INCORPORATION
A61K35/747A61P1/14A61K2035/115
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,639,336
App. No.
16/435,944
Granted
May 5, 2020
Kind
B1
Abstract

The present invention provides a composition for preventing stroke and ameliorating the severity of stroke and comprises an effective dose of Lactobacillus reuteri GMNL-89 and Lactobacillus paracasei GMNL-133; the accession number of Lactobacillus reuteri GMNL-89 is CCTCC M207154 and the accession number of Lactobacillus paracasei GMNL-133 is CCTCC M2011331. The composition can be taken as a dietary supplement and be given continuously after a stroke, and said composition has the effects of ameliorating cerebral infarction, motor function, and intestinal microbiota after a stroke.

Claims (6)

1. A method used for ameliorating a severity of a stroke, comprising administrating a probiotic composition, wherein the probiotic bacterial strain is selected from the groups consisting of Lactobacillus reuteri GMNL-89 with the deposition number of CCTCC M207154, and Lactobacillus paracasei GMNL-133 with the deposition number of CCTCC M2011331.

2. The method as claimed in claim 1 , wherein ameliorating stroke is ameliorating ischemic stroke.

3. The method as claimed in claim 1 , wherein ameliorating stroke is ameliorating cerebral infarction caused by stroke.

4. The method as claimed in claim 1 , wherein ameliorating stroke is ameliorating the recovery status of the patient after a stroke.

5. The method as claimed in claim 1 , wherein the recovery status of the patient is motor function.

6. The method as claimed in claim 1 , wherein the dose of the probiotics is 1×10 7 ˜1×10 10 live bacteria per day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2019
From: CHEN, YI-HSING; TSAI, WAN-HUA; HUANG, SHIANG-SUO; WANG, YI-HSIN
To: GENMONT BIOTECH INCORPORATION
Reel/Frame 049418/0891 →